Walleye Capital’s Rapid Micro Biosystems RPID Stock Holding History

Walleye Capital’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,660	Closed	-$345	–	2282
2021 Q3	$345	Buy	+18,660	New	+$385K	0.01%	942

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Walleye Capital's RPID Position: Q4 2021 in Review

Walleye Capital sold out of Rapid Micro Biosystems (RPID) in Q4 2021, closing a stake of 18,660 shares — an estimated $345 sold.

Walleye Capital first reported a position in RPID in Q3 2021 and held it in 1 quarter. The position peaked at $345 in Q3 2021. 55 funds tracked by Wall St. Rank hold RPID as of Q4 2021.

Walleye Capital reported no remaining Rapid Micro Biosystems position as of Q4 2021 after selling out during the quarter.
Walleye Capital sold 18,660 Rapid Micro Biosystems shares in Q4 2021, an estimated $345.
Walleye Capital first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 1 quarter.
Walleye Capital's Rapid Micro Biosystems position peaked at $345 in Q3 2021.
55 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q4 2021.

Based on Walleye Capital's 13F filing for Q4 2021, filed 3 Mar 2022.